| 摘要 |
The invention relates to the use of in-vitro gene expression profiles, obtained from a patient, for the generation of criteria for the prediction o f an individual disease course in sepsis. The invention is further of use for determining the probability of survival in sepsis, the course evaluation of sepsis during treatment and for the classification of sepsis patients.</SDOA B> |
